We bring together leading
ultrasound experts

Aritz, CEO of Resolve Stroke, is a seasoned professional with over 7 years of experience in Healthcare, Tech, and Private Equity support. Prior to founding Resolve Stroke, he was a valued member of the Roland Berger Healthcare global core team, a key strategy consulting firm. Aritz brings a unique blend of skills and knowledge to drive Resolve Stroke. Aritz’s expertise stems from his cross-disciplinary academic background, with degrees in Medical Sciences from Imperial College London, Business from HEC Paris, and Engineering from CentraleSupélec.

Vincent is a renouned expert in biomedical ultrasounds and a pioneer in software-driven ultrasound methods. He co-founded Resolve Stroke after close to ten years in world class laboratories including as a visiting researcher at Harvard University, USA, co-writing more than twenty papers and four patents. Vincent brings a solid technical expertise from his academic background and original engineering degree from ESPCI. He brings his experience of conducting clinical research and a solid network of clinicians.

CNRS Research Director, team leader at the Biomedical Imaging Laboratory (Sorbonne Université, CNRS, INSERM), Paris, France

Olivier Couture is a distinguished figure in the field of medical imaging and ultrasound technology. With a deep expertise in non-invasive diagnostic techniques, he has significantly contributed to advancing the accuracy and efficacy of ultrasound diagnostics with several scientific publications for instance in Nature.

Maxence is a seasoned software engineer with experience spanning academia and industry, currently leading the software engineering at Resolve Stroke. In his academic journey, he studied engineering at CentraleSupelec, completed a PhD in Computer Science at Inria, and conducted research in computational geometry at UCLouvain. Post-academia, Maxence joined Siemens Digital Industries Software to contribute to their High-Performance Computing Multiphysics simulation software. At ResolveStroke, Maxence leverages his extensive scientific computing knowledge and industry experience to help the company achieve its ambitious goals.

Lise, in charge of clinical partnerships at Resolve Stroke, brings strong scientific expertise through her engineering degree from ESPCI Paris and her PhD from Sorbonne Université conducted at Pitié-Salpêtrière Hospital.

At Resolve Stroke, she plays a pivotal role in translating physicians’ clinical requirements into actionable R&D objectives, to ensure our innovation roadmap remains firmly grounded in addressing real-world medical challenges. By coordinating with medical teams and driving integration of our technologies into clinical workflows, Lise helps shape solutions that genuinely respond to practitioners’ and patients’ needs.

Georges Chabouh is an internationally recognized expert in biomedical research. At Sorbonne University, he pioneered cutting-edge ultrasound imaging for clinical diagnostics, while at Columbia University in New York, he drove innovations in ultrasound-based therapies, including neuromodulation and drug/gene delivery. Georges holds prestigious honors such as the Marie Skłodowska-Curie Actions Seal of Excellence and the PEPS CNRS award, has co-authored over twenty scientific papers, and chaired the Gordon Research Seminar.

At Resolve Stroke, Georges spearheads ultrasound software innovation, focusing on unlocking new neuro indications and expanding clinical applications. He specializes in designing clinical trials and translating the needs of U.S. healthcare professionals into our technology roadmap—bridging the gap between the R&D team and the clinic. Dedicated to identifying and addressing clinical needs, Georges channels direct feedback from healthcare teams into product development, ensuring our solutions truly serve real-world practice.

Dr. Anthony Samir is a Professor at Harvard Medical School, and a Diagnostic and Interventional Radiologist at the Massachusetts General Hospital, where he serves as Service Chief for Body Ultrasound Imaging Services. He has an extensive clinical leadership experience in a high-volume service comprising 50 technologists at 10 sites read by ~110 radiologists. He is a serial inventor, with five inventor’s prizes for medical devices and multiple patents. With his internationally recognized expertise in quantitative biomarker development, medical devices, applied machine learning, ultrasound, cancer, liver disease, and thyroid disease, he is a key asset for Resolve Stroke. As Resolve Stroke’s advisor, he brings his extensive experience with technology transition to industry and with executing at multiple levels: entrepreneur, board roles.

Sylvain Bodard currently conducts clinical research at Memorial Sloan Kettering in New York and Harvard University in Boston, US. He is a Clinical Fellow at Necker Hospital, Paris Cité University in Paris, France. In this role, he performs and supervises scheduled and on-call image-guided interventional radiology procedures for both inpatients and outpatients. His responsibilities include patient triage and admission, as well as the protocol/readout of diagnostic x-ray, computed tomography, and magnetic resonance imaging studies. His previous research in France (Sorbonne University, CNRS, INSERM, LIB, SMAER, Paris) and today in the US focuses on advancing medical imaging techniques and furthering the understanding and treatment of various medical conditions.

MD. Clement Gakuba, coordinator at CHU de Caen Normandie, is a seasoned professional with over 7 years of experience in Anesthesiology and Intensive Care. He holds a critical role as a referring physician in surgical intensive care. His past experiences include being a postdoctoral researcher at Harvard Medical School and an associate researcher at Inserm. MD. Gakuba’s expertise stems from his diverse academic and professional background, with a Doctorate in Medicine and a Master’s degree in Medical Sciences from Inserm laboratory.

Denis Vivien, Professor and Research Director at Inserm and CHU de Caen Normandie, is an esteemed professional with a diverse background in molecular biology and neuroscience. He leads a team of 140 at Inserm, driving groundbreaking research on the central nervous system. Prior to establishing his lab, Vivien completed a postdoctoral position at the Sloan Kettering Cancer Center, further enriching his expertise. His unique blend of skills and knowledge has led to significant discoveries, particularly on the tissue plasminogen activator (tPA), which promises to revolutionize stroke treatment. His work has been recognized internationally, most notably with the 2023 Prix Danièle Hermann.

Vivien Szabo, Anesthesiologist and Researcher in the department of Anesthesiology and Critical Care Medicine at Montpellier University Hospital (France) combines his medical practice with cutting-edge research in neuroscience. After training at the medical school of Montpellier, he joined the Inserm Liliane Bettencourt School – MD-PhD program, where he mastered cellular biology and BRET microscopy. His doctoral studies in Serge Charpak’s laboratory led to significant advancements in simultaneous calcium imaging and photoactivation with cellular resolution. Now, as part of Julie Perroy’s team, he continues to develop innovative in vivo microscopy techniques to investigate physiological and pathological synaptic transmission. His unique blend of clinical practice and research makes him a valuable contributor to the field of neuroscience.

MD-PhD. Maxime Gauberti is an Interventional Neuroradiologist in the Department of Neuroradiolology at Caen-Normandie University Hospital. Alongside his clinical practice, he spent over 11 years as a Postdoctoral Fellow at INSERM Laboratory, contributing to advancements in neurosciences. MD. Gauberti has an extensive training in medical sciences, human anatomy, and physiology to diagnose and treat various medical conditions. His academic and professional journey illustrates his commitment to advancing healthcare through research and clinical practice.

Brian McEathron was General Manager, General Imaging Ultrasound at General Electric HealthCare division. Brian brings an experience of +24 years in marketing, sales, and customer applications. He has in depth knowledge of the healthcare issues and disparities that exist. He led global teams from engineering, and manufacturing at GE Health Care division. He has worked very closely with the top healthcare providers from around the globe.

François Tranquart, MD, PhD, is a globally recognized leader with deep expertise in medical imaging and clinical development. He formerly served as Global Head of Clinical Development at GE Healthcare and was previously General Manager at Bracco Suisse. In these roles, he led worldwide clinical programs across oncology, cardiovascular imaging, and molecular diagnostics.
A pioneer in contrast-enhanced ultrasound, François played a key role in the development of cutting-edge technologies.
He serves as a trusted advisor to organizations at the forefront of imaging technology, clinical validation, and market access.

David, who co-founded Implicity with Arnaud Rosier in 2016, now serves as Chief Innovation Officer. Under his leadership, the company has developped innovative AI algorithms based on cardiac data. The company is now the European leader in telemonitoring of implantable cardiac devices and remote patient monitoring. In 2022, they raised a 21m euros Serie A. Aligned with Resolve Stroke’s ambition, David brings his visionary approach to data management in the healthcare industry.

Julien Gautier joined Roland Berger in 2006, where he has excelled in leading strategic planning missions, supporting product launches, enhancing operational and financial performance, and providing restructuring and pre- and post-merger support for acquisitions in the health and MedTech sectors. His expertise is valued by both public and private actors, contributing to various aspects of the industry. With over 15 years of professional experience as a consultant in the MedTech and Healthcare Industry, Julien’s advice is invaluable for Resolve Stroke.